Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 7/22/2017 2:52:10 AM - Followers: 704 - Board type: Free - Posts Today: 8

Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.

Patent Info:

Clinical Trials:
Recent News:
Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board 07/20/2017 07:00:00 AM
AVXL News: Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments 06/15/2017 07:00:00 AM
AVXL News: Notice of Effectiveness (effect) 06/13/2017 06:03:09 AM
AVXL News: Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference 06/05/2017 07:00:00 AM
AVXL News: Securities Registration Statement (simplified Form) (s-3) 05/26/2017 04:32:21 PM
#109577  Sticky Note Requested Dosing Extension falconer66a 06/24/17 10:45:47 PM
#108606  Sticky Note Lots of negativity on the board today. sliceanddice59 06/15/17 01:27:12 AM
#103034  Sticky Note To answer your good questions. falconer66a 04/26/17 10:18:09 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#112309   Yes, I agree. Pure coincidence. ;-) Citrati 07/22/17 02:52:09 AM
#112308   C,theres already some interesting things to see in 123tom 07/22/17 02:23:56 AM
#112307   Your dilution rational does not make sense in jimmy667 07/22/17 02:14:51 AM
#112306   Way Off! False because both you and F1ash F1ash 07/22/17 01:53:42 AM
#112305   Perhaps you don't understand the nature and boom Citrati 07/22/17 12:57:38 AM
#112303   Way Off! False because both you and F1ash jimmy667 07/22/17 12:20:44 AM
#112302   Anavex 2-73 and Anavex 3-71 to treat ALS georgejjl 07/22/17 12:10:10 AM
#112301   F1ash is 100% correct. The last time we abew4me 07/21/17 11:57:29 PM
#112300   I think it’s interesting the new SAB guy, tradeherpete 07/21/17 11:35:32 PM
#112299   Great post fireman I could not agree more. Gernee20 07/21/17 11:18:46 PM
#112298   the fear of nmissing the upward move.... 123tom 07/21/17 11:11:00 PM
#112297   I seriously doubt that there will be a Steady_T 07/21/17 11:07:28 PM
#112296   That was nice. good luck and be careful indebt2 07/21/17 10:19:47 PM
#112295   Interesting, but I don't trade. Too scared Jimmy6969 07/21/17 10:04:57 PM
#112294   They were only able to take it down Gator328 07/21/17 10:04:52 PM
#112293   Yes BA. And hence why until McMagyar 07/21/17 09:44:09 PM
#112292   Oh that's a terrible thing to 123tom 07/21/17 09:33:44 PM
#112291   I had a stink bid in at $3.75 Steady_T 07/21/17 09:21:41 PM
#112290   No sweat Mike. I enjoy this board as Fireman02360 07/21/17 09:21:04 PM
#112289   now this is what a "First ever post" 123tom 07/21/17 09:07:47 PM
#112288   yes,for now. 123tom 07/21/17 08:41:48 PM
#112287   good luck in BC.... 123tom 07/21/17 08:35:19 PM
#112286 Penny Double 07/21/17 08:31:48 PM
#112285   Yo Fireman, lqmike 07/21/17 08:16:55 PM
#112284   The chart from half a year ago... 123tom 07/21/17 08:16:32 PM
#112283   "So the bottom is now 3.63" So the bottom scottsmith 07/21/17 08:13:30 PM
#112282   Thanks for you insight Tom. Youve been spot Fireman02360 07/21/17 08:11:42 PM
#112281   CEOs and Shorting: Fireman02360 07/21/17 08:01:32 PM
#112280   you did good Fireman... 123tom 07/21/17 07:53:58 PM
#112278   You were seeing the picture,Gator. 123tom 07/21/17 07:36:55 PM
#112277   While I definitely understand the negative optics and polarbear77 07/21/17 07:27:46 PM
#112276   Hi Tom, Fireman02360 07/21/17 07:23:25 PM
#112275   Smart to put in the IRA. Long term Gator328 07/21/17 07:22:06 PM
#112274   Anavex will be nowhere near the top. We Gator328 07/21/17 07:20:45 PM
#112273   Remember a few weeks ago I called this Gator328 07/21/17 07:18:40 PM
#112272   could be better,that couldnt be said better 123tom 07/21/17 07:14:48 PM
#112271   All small cap pharmas are subject to these couldbebetter 07/21/17 07:05:06 PM
#112270   Yes action. Williamsc 07/21/17 06:54:08 PM
#112269   Missling is an experienced M&A and CFO guy. roygbiv 07/21/17 06:37:28 PM
#112267   Simply put - the FDA is in organizational roygbiv 07/21/17 06:20:26 PM
#112265   This is just my biggest speculative must TheBigTicket 07/21/17 06:11:58 PM
#112262   This will continue till we get into next A_Good_Day_2 07/21/17 05:58:48 PM
#112261   Me to, it really, really sucks. The fact nidan7500 07/21/17 05:57:20 PM
#112260   Totally a fundamental (or lack thereof) move that's scottsmith 07/21/17 05:51:18 PM
#112259   Wow....that's all I can say right now... 123tom 07/21/17 05:50:02 PM
#112256   You do not get it, they will hit nidan7500 07/21/17 05:40:58 PM
#112255   Expectations of PKPD data....None Kentucky123 07/21/17 05:27:56 PM
#112254   Why blame FDA? Any trial for new indication even Amatuer17 07/21/17 05:18:00 PM
#112253   SLB chart, updated EOD 21Jun2017, no significant change wildcard235 07/21/17 05:08:18 PM
#112252   A solid update would have out paced selling. Williamsc 07/21/17 05:05:07 PM